• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部鳞癌患者不同组织中癌症干细胞标志物 ALDH1A1、BCL11B、BMI-1 和 CD44 的鉴别。

Discrimination of Cancer Stem Cell Markers ALDH1A1, BCL11B, BMI-1, and CD44 in Different Tissues of HNSCC Patients.

机构信息

Department of Otolaryngology, University Hospital, LMU Munich, 81377 Munich, Germany.

Institute of Pathology, Faculty of Medicine, LMU Munich, 81377 Munich, Germany.

出版信息

Curr Oncol. 2021 Jul 19;28(4):2763-2774. doi: 10.3390/curroncol28040241.

DOI:10.3390/curroncol28040241
PMID:34287293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8293237/
Abstract

Cancer stem cells (CSCs) are accountable for the progress of head and neck squamous cell carcinoma (HNSCC). This exploratory study evaluated the expression of molecular CSC markers in different tissues of HNSCC patients. Tissue specimens of primary tumor, lymph node metastases and macroscopically healthy mucosa of 12 consecutive HNSCC patients, that were treated with surgery and adjuvant radio(chemo)therapy upon indication, were collected. Samples were assessed for the expression of p16 as a surrogate for HPV-related disease and different molecular stem cell markers (ALDH1A1, BCL11B, BMI-1, and CD44). In the cohort, seven patients had HPV-related HNSCC; six thereof were oropharyngeal squamous cell carcinoma. While expression of BMI-1 and BCL11B was significantly lower in healthy mucosa than both tumor and lymph node metastasis, there were no differences between tumor and lymph node metastasis. In the HPV-positive sub-cohort, these differences remained significant for BMI-1. However, no significant differences in these three tissues were found for ALDH1A1 and CD44. In conclusion, this exploratory study shows that CSC markers BMI-1 and BCL11B discriminate between healthy and cancerous tissue, whereas ALDH1A1 and CD44 were expressed to a comparable extent in healthy mucosa and cancerous tissues.

摘要

癌症干细胞(CSC)是导致头颈部鳞状细胞癌(HNSCC)进展的原因。本探索性研究评估了分子 CSC 标志物在 HNSCC 患者不同组织中的表达。连续 12 例 HNSCC 患者的手术和辅助放化疗适应证的原发肿瘤、淋巴结转移和宏观健康黏膜的组织标本均被收集。评估了 p16 作为 HPV 相关疾病和不同分子干细胞标志物(ALDH1A1、BCL11B、BMI-1 和 CD44)的表达。在该队列中,7 例患者为 HPV 相关 HNSCC;其中 6 例为口咽鳞状细胞癌。BMI-1 和 BCL11B 的表达在健康黏膜中明显低于肿瘤和淋巴结转移,而肿瘤和淋巴结转移之间无差异。在 HPV 阳性亚组中,BMI-1 的这些差异仍然显著。然而,ALDH1A1 和 CD44 在这三种组织中的表达没有显著差异。总之,这项探索性研究表明,CSC 标志物 BMI-1 和 BCL11B 可区分健康组织和癌组织,而 ALDH1A1 和 CD44 在健康黏膜和癌组织中的表达程度相当。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4330/8293237/4c178f587903/curroncol-28-00241-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4330/8293237/3d9d4615ab62/curroncol-28-00241-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4330/8293237/2396512214be/curroncol-28-00241-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4330/8293237/4c178f587903/curroncol-28-00241-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4330/8293237/3d9d4615ab62/curroncol-28-00241-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4330/8293237/2396512214be/curroncol-28-00241-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4330/8293237/4c178f587903/curroncol-28-00241-g003.jpg

相似文献

1
Discrimination of Cancer Stem Cell Markers ALDH1A1, BCL11B, BMI-1, and CD44 in Different Tissues of HNSCC Patients.头颈部鳞癌患者不同组织中癌症干细胞标志物 ALDH1A1、BCL11B、BMI-1 和 CD44 的鉴别。
Curr Oncol. 2021 Jul 19;28(4):2763-2774. doi: 10.3390/curroncol28040241.
2
Role of cancer stem cell markers ALDH1, BCL11B, BMI-1, and CD44 in the prognosis of advanced HNSCC.癌干细胞标志物 ALDH1、BCL11B、BMI-1 和 CD44 在晚期头颈部鳞癌预后中的作用。
Strahlenther Onkol. 2021 Mar;197(3):231-245. doi: 10.1007/s00066-020-01653-5. Epub 2020 Jun 25.
3
Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).评估原发性头颈部鳞状细胞癌中癌症干细胞标志物的表达,显示醛脱氢酶(ALDH1A1)的预后价值。
Eur J Pharmacol. 2020 Jan 15;867:172837. doi: 10.1016/j.ejphar.2019.172837. Epub 2019 Dec 5.
4
MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.微小 RNA-200c 可减弱疑似头颈部鳞状细胞癌干细胞的肿瘤生长和转移。
J Pathol. 2011 Mar;223(4):482-95. doi: 10.1002/path.2826. Epub 2011 Jan 5.
5
Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma.醛脱氢酶1A1阳性癌症干细胞在局部晚期、转移性头颈部鳞状细胞癌患者中的预后意义
J Cancer Res Clin Oncol. 2014 Jul;140(7):1151-8. doi: 10.1007/s00432-014-1685-4. Epub 2014 Apr 27.
6
Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.癌症干细胞标志物 CD44 和 ALDH1 用于评估 OPMD 中的癌症风险和口腔鳞状细胞癌中的淋巴结转移。
Head Neck Pathol. 2022 Jun;16(2):453-465. doi: 10.1007/s12105-021-01384-8. Epub 2021 Oct 16.
7
Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells.葫芦素 I 抑制了头颈部鳞状细胞癌来源的 CD44(+)ALDH1(+)细胞的干性特征,并增强了放射诱导的细胞凋亡。
Mol Cancer Ther. 2010 Nov;9(11):2879-92. doi: 10.1158/1535-7163.MCT-10-0504. Epub 2010 Nov 9.
8
Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.PI3K和SOX2对头颈部鳞状细胞癌干细胞的调控
J Natl Cancer Inst. 2016 Sep 15;109(1). doi: 10.1093/jnci/djw189. Print 2017 Jan.
9
Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.人类头颈部鳞状细胞癌中表面标志物 CD271 和 CD44 的癌症干细胞富集。
Carcinogenesis. 2020 Jun 17;41(4):458-466. doi: 10.1093/carcin/bgz182.
10
Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer.量子点技术与传统免疫组织化学在检测头颈部癌淋巴结转移潜在生物标志物醛脱氢酶 1A1 中的比较。
Eur J Cancer. 2012 Jul;48(11):1682-91. doi: 10.1016/j.ejca.2011.12.029. Epub 2012 Feb 15.

引用本文的文献

1
Nanoparticle delivery of a prodrug-activating bacterial enzyme leads to anti-tumor responses.纳米颗粒递送前药激活细菌酶可引发抗肿瘤反应。
Nat Commun. 2025 Apr 12;16(1):3490. doi: 10.1038/s41467-025-58548-1.
2
An angiogenesis-associated gene-based signature predicting prognosis and immunotherapy efficacy of head and neck squamous cell carcinoma patients.一个与血管生成相关的基因特征,可预测头颈部鳞状细胞癌患者的预后和免疫治疗疗效。
J Cancer Res Clin Oncol. 2024 Feb 12;150(2):91. doi: 10.1007/s00432-024-05606-8.
3
The Impact of YRNAs on HNSCC and HPV Infection.

本文引用的文献

1
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
2
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
3
Prediction of post-radiotherapy locoregional progression in HPV-associated oropharyngeal squamous cell carcinoma using machine-learning analysis of baseline PET/CT radiomics.
YRNAs对头颈部鳞状细胞癌和人乳头瘤病毒感染的影响。
Biomedicines. 2023 Feb 23;11(3):681. doi: 10.3390/biomedicines11030681.
4
Relationship between Tumor Budding and Partial Epithelial-Mesenchymal Transition in Head and Neck Cancer.头颈癌中肿瘤芽生与部分上皮-间质转化之间的关系
Cancers (Basel). 2023 Feb 9;15(4):1111. doi: 10.3390/cancers15041111.
5
Bmi-1: A master regulator of head and neck cancer stemness.Bmi-1:头颈癌干性的主要调节因子。
Front Oral Health. 2023 Jan 16;4:1080255. doi: 10.3389/froh.2023.1080255. eCollection 2023.
6
Association between cancer stem cell gene expression signatures and prognosis in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中癌症干细胞基因表达特征与预后的相关性。
BMC Cancer. 2022 Oct 19;22(1):1077. doi: 10.1186/s12885-022-10184-4.
7
Differential Markers of Subpopulations of Epithelial Cells of the Larynx in Squamous Cell Carcinoma.喉鳞状细胞癌中上皮细胞亚群的差异标志物。
Bull Exp Biol Med. 2022 Aug;173(4):553-559. doi: 10.1007/s10517-022-05588-y. Epub 2022 Sep 12.
8
Heterogeneity of Cancer Stem Cells in Tumorigenesis, Metastasis, and Resistance to Antineoplastic Treatment of Head and Neck Tumours.头颈部肿瘤发生、转移及抗肿瘤治疗耐药中的肿瘤干细胞异质性。
Cells. 2021 Nov 8;10(11):3068. doi: 10.3390/cells10113068.
利用基线PET/CT影像组学的机器学习分析预测人乳头瘤病毒相关口咽鳞状细胞癌放疗后局部区域进展情况
Transl Oncol. 2021 Jan;14(1):100906. doi: 10.1016/j.tranon.2020.100906. Epub 2020 Oct 16.
4
Potential Added Value of PET/CT Radiomics for Survival Prognostication beyond AJCC 8th Edition Staging in Oropharyngeal Squamous Cell Carcinoma.PET/CT影像组学在口咽鳞状细胞癌中超越美国癌症联合委员会第8版分期进行生存预后评估的潜在附加价值
Cancers (Basel). 2020 Jul 3;12(7):1778. doi: 10.3390/cancers12071778.
5
Role of cancer stem cell markers ALDH1, BCL11B, BMI-1, and CD44 in the prognosis of advanced HNSCC.癌干细胞标志物 ALDH1、BCL11B、BMI-1 和 CD44 在晚期头颈部鳞癌预后中的作用。
Strahlenther Onkol. 2021 Mar;197(3):231-245. doi: 10.1007/s00066-020-01653-5. Epub 2020 Jun 25.
6
Oropharyngeal HPV Detection Techniques in HPV-associated Head and Neck Cancer Patients.口咽 HPV 检测技术在 HPV 相关头颈癌患者中的应用。
Anticancer Res. 2020 Apr;40(4):2117-2123. doi: 10.21873/anticanres.14170.
7
The molecular markers of cancer stem cells in head and neck tumors.头颈部肿瘤中癌症干细胞的分子标志物。
J Cell Physiol. 2020 Jan;235(1):65-73. doi: 10.1002/jcp.28963. Epub 2019 Jun 17.
8
A systematic review of the HPV-attributable fraction of oropharyngeal squamous cell carcinomas in Germany.德国 HPV 相关口咽鳞癌发病比例的系统性综述。
Cancer Med. 2019 Apr;8(4):1908-1918. doi: 10.1002/cam4.2039. Epub 2019 Mar 1.
9
Expression of Cancer Stem Cell Biomarkers in Human Head and Neck Carcinomas: a Systematic Review.癌症干细胞标志物在人类头颈部癌中的表达:系统评价。
Stem Cell Rev Rep. 2018 Dec;14(6):769-784. doi: 10.1007/s12015-018-9839-4.
10
CD44 and ALDH1 immunoexpression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma.CD44 和 ALDH1 的免疫表达可作为口腔鳞状细胞癌侵袭和转移的预后指标。
J Oral Pathol Med. 2018 Sep;47(8):740-747. doi: 10.1111/jop.12734. Epub 2018 Jun 1.